|
Volumn 2, Issue 6, 2002, Pages 429-431
|
Vaccination against tumor neovascularization: Promise and reality
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BASIC FIBROBLAST GROWTH FACTOR RECEPTOR;
CANCER VACCINE;
CD51 ANTIGEN;
DNA VACCINE;
LYMPHOCYTE ANTIGEN;
VASCULOTROPIN RECEPTOR 2;
VITRONECTIN RECEPTOR;
ANGIOGENESIS;
CANCER IMMUNOTHERAPY;
COLON CARCINOMA;
CYTOTOXIC T LYMPHOCYTE;
DENDRITIC CELL;
HUMAN;
IMMUNE RESPONSE;
IMMUNOLOGICAL TOLERANCE;
LEWIS CARCINOMA;
LUNG METASTASIS;
PRIORITY JOURNAL;
RECEPTOR AFFINITY;
SHORT SURVEY;
SIGNAL TRANSDUCTION;
TUMOR VASCULARIZATION;
UPREGULATION;
WOUND HEALING;
ANIMAL;
GENETIC ENGINEERING;
IMMUNOLOGY;
NEOPLASM;
NEOVASCULARIZATION (PATHOLOGY);
REVIEW;
VASCULAR ENDOTHELIUM;
VASCULARIZATION;
ANIMALS;
CANCER VACCINES;
ENDOTHELIUM, VASCULAR;
GENETIC ENGINEERING;
HUMANS;
IMMUNE TOLERANCE;
NEOPLASMS;
NEOVASCULARIZATION, PATHOLOGIC;
VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;
|
EID: 1242265805
PISSN: 15356108
EISSN: None
Source Type: Journal
DOI: 10.1016/S1535-6108(02)00208-8 Document Type: Review |
Times cited : (30)
|
References (10)
|